Funding Opportunities

• Secondary Analyses of Existing Alcohol Research Data (R01)
  (PA-17-467)
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Secondary Analyses of Existing Alcohol Research Data (R03)
  (PA-17-468)
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Continuation of Existing Grant Based Epidemiology Cohort Studies in Heart, Lung, Blood, and Sleep Diseases and Disorders (U01)
  (PAR-17-338)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): February 22, 2018, February 21, 2019, February 20, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Bench Testing Therapeutic/Indication Pairing Strategies (UG3/UH3)
  (PAR-17-465)
  National Center for Advancing Translational Sciences
  National Center for Advancing Translational Sciences
  Application Receipt Date(s): October 30, 2017, February 28, 2018, June 26, 2018, October 30, 2018, February 27, 2019, June 26, 2019, October 30, 2019, February 27, 2020, June 26, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Clinical and Epidemiological Research on Chronic Disease in the Caribbean (R01)
  (PAR-17-470)
  National Institute on Minority Health and Health Disparities
  National Institute on Aging
  National Cancer Institute
  National Heart, Lung, and Blood Institute
  National Institute of Nursing Research
  Application Receipt Date(s): November 15, 2017, November 15, 2018, November 15, 2019),, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Detection of HIV for Self-Testing (R61/R33)
  (PAR-17-471)
  National Institute of Allergy and Infectious Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Mental Health
  Application Receipt Date(s): December 6, 2017, December 6, 2018, and December 6, 2019 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Alcoholic Hepatitis Clinical and Translational Network Late Phase Clinical Trials and Observational Studies (Collaborative U01)
  (RFA-AA-18-002)
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): October 23, 2017), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted in response to this FOA. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Alcoholic Hepatitis Clinical and Translational Network Translational Research (U01)
  (RFA-AA-18-003)
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): October 23, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted in response to this FOA. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Alcoholic Hepatitis Clinical and Translational Network Data Coordinating Center (U24)
  (RFA-AA-18-004)
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): October 23, 2017), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted in response to this FOA. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Alcoholic Hepatitis Clinical and Translational Network Clinical Pilot Trials (U01)
  (RFA-AA-18-005)
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): October 23, 2017), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. No late applications will be accepted in response to this FOA.
• Alcoholic Hepatitis Clinical and Translational Network Basic and Pre-Clinical Research (UH2/UH3)
  (RFA-AA-18-006)
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): October 23, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted in response to this FOA. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• NIH Blueprint for Neuroscience Research: Dynamic Neuroimmune Interactions in the Transition from Normal CNS Function to Disorders (R01)
  (RFA-AA-18-007)
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Environmental Health Sciences
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Mental Health
  National Institute of Nursing Research
  National Institute of Neurological Disorders and Stroke
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  NIH Blueprint for Neuroscience Research
  National Center for Advancing Translational Sciences
  Application Receipt Date(s): December 7, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on December 7, 2017 No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Partnerships for Countermeasures Against Select Pathogens (R01)
  (RFA-AI-17-026)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): January 12, 2018 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Consortium on Translational Research in Early Detection of Liver Cancer (Clinical and Research Centers (U01)
  (RFA-CA-17-025)
  National Cancer Institute
  Application Receipt Date(s): October 24, 2017, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this FOA. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Coordinating Center for the Consortium of Translational Research in Early Detection of Liver Cancer (U24)
  (RFA-CA-17-028)
  National Cancer Institute
  Application Receipt Date(s): October 24, 2017, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this FOA. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Catalyst Award in Diabetes, Endocrinology and Metabolic Diseases (DP1- Clinical Trial Not Allowed)
  (RFA-DK-17-011)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): February 2, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Stimulating Access to Research in Residency (StARR) (R38)
  (RFA-HL-18-023)
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Cancer Institute
  Application Receipt Date(s): October 24, 2017, February 13, 2019, and February 13, 2020, by 5:00 PM local time of applicant organization. All non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Research Centers in Minority Institutions (RCMI) (U54)
  (RFA-MD-17-006)
  National Institute on Minority Health and Health Disparities
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): December 15, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
• BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R01)
  (RFA-MH-18-500)
  National Institute of Mental Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  Application Receipt Date(s): December 7, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date